Anti-cold detoxification capsule pharmaceutical composition as well as preparation method and application thereof

By preparing anti-sensory detoxification capsule pharmaceutical compositions containing ingredients such as Angelica dahurica and Scutellaria baicalensis, the problems of complex drug ingredients and unclear efficacy were solved, better treatment effects for wind-heat colds were achieved, and the quality and safety of the drug were ensured.

CN118987078AActive Publication Date: 2024-11-22QINHUANGDAO SHANHAIGUAN PHARMACEUTICAL CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411126427.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-22
Estimated Expiration
2044-08-16

AI Technical Summary

Technical Problem

The drug ingredients of Kangganjiedu Capsule are complex and has unclear efficacy, making it difficult to improve the efficacy of treating wind-heat colds and complications of inflammation.

Method used

Using a pharmaceutical composition composed of angelica dahurica, scutellaria baicalensis, flavonoids, erocanthus, intranatinone, phlogenetic compounds and organic acids, an oral preparation is formed through specific extraction and mixing steps, and the oral preparation is formed using In the treatment of influenza, mumps, and encephalitis caused by wind-heat colds and viruses.

Benefits of technology

It has improved the prevention and treatment effect of wind-heat colds, clarified the effective ingredients, ensured the quality and safety of the drug, and found that erocene and intracene have synergistic effects in antipyretic and analgesic.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004996555870000021
    Figure BDA0004996555870000021
  • Figure BDA0004996555870000031
    Figure BDA0004996555870000031
  • Figure BDA0004996555870000051
    Figure BDA0004996555870000051
Patent Text Reader

Abstract

The invention belongs to the field of traditional Chinese medicine treatment, and particularly relates to an anti-cold detoxification capsule pharmaceutical composition as well as a preparation method and application thereof. The composition is prepared from the following components in parts by weight: 25 to 35 parts of radix angelicae dahuricae, 40 to 50 parts of radix scutellariae, 2 to 5 parts of flavonoid compounds, 0.5 to 2 parts of imperatorin, 1 to 5 parts of capillary acetylenic ketone, 1 to 5 parts of phloroglucinol compounds and 0.1 to 0.5 part of organic acid. The split composition provided by the invention has a good effect of preventing and treating wind-heat type common cold, and all the components have a relatively good synergistic effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of traditional Chinese medicine treatment, and specifically relates to an anti-inflammation and detoxification capsule pharmaceutical composition, a preparation method and an application thereof. Background Art

[0002] Kanggan Jiedu Capsule is a hospital preparation composed of 11 Chinese medicinal herbs including honeysuckle, isatis root, scutellaria baicalensis, etc. It is clinically used for wind-heat cold and influenza, mumps, encephalitis and other diseases caused by viruses, and has good efficacy. This standard is specially formulated to better control the quality of drugs and ensure the safety and effectiveness of clinical drug use.

[0003] Kanggan Jiedu Capsule has many medicinal flavors and complex ingredients, which brings many disadvantages to the research on the material basis of drug action, and its efficacy in treating wind-heat cold and its concurrent inflammation needs to be further improved. Simplifying the formula and accurately matching the active ingredients are of great significance to the explanation of the mechanism of drug action, and how to choose to achieve higher efficacy is a technical issue that needs to be solved urgently for complex prescriptions. Summary of the invention

[0004] In order to overcome the deficiencies of the prior art, the present invention provides a Kanggan Jiedu capsule pharmaceutical composition and a preparation method and application thereof. Kanggan Jiedu capsule medicine clears away heat and detoxifies, and is used for wind-heat cold and influenza.

[0005] The purpose of the present invention is achieved through the following technical solutions:

[0006] The Kanggan Jiedu capsule pharmaceutical composition is composed of the following components in parts by weight: 25-35 parts of Angelica dahurica, 40-50 parts of Scutellaria baicalensis, 2-5 parts of flavonoid compounds, 0.5-2 parts of imperatorin, 1-5 parts of capillarin ketone, 1-5 parts of phloroglucinol compounds, and 0.1-0.5 parts of organic acids.

[0007] Furthermore, the phloroglucinol compound includes ABA and ABBA in a mass ratio of 1-5:1.

[0008] Furthermore, the organic acid is selected from one or more of oleanolic acid, vanillic acid and lauric acid.

[0009] Furthermore, the organic acid is oleanolic acid.

[0010] Furthermore, the flavonoid compound comprises a mixture of forsythiaside A, puerarin and luteolin in a mass ratio of 1:0.5-1:1-3 in parts by weight.

[0011] Another object of the present invention is to provide a method for preparing the above composition, comprising the following steps:

[0012] (1) mixing Angelica dahurica and Scutellaria baicalensis, adding additives for soaking pretreatment, filtering, adding water for extraction, and obtaining a residue 1 and an extract 1;

[0013] (2) extracting the residue 1 with ethanol, filtering, and obtaining an extract 2;

[0014] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain an extract;

[0015] (4) The extract, flavonoid compounds, imperatorin, capillary ketone, phloroglucinol compounds and organic acid are mixed to obtain the product.

[0016] Furthermore, the additive in step (1) is an aqueous solution containing 0.02-0.05% lecithin and 0.01-0.02% polyglycerol fatty acid ester by mass concentration;

[0017] Preferably, the polyglycerol fatty acid ester is preferably triglycerol monostearate;

[0018] Furthermore, the pretreatment time in step (1) is 20-40 min;

[0019] Furthermore, the extraction temperature in step (1) is 60-70°C, the number of extractions is 1-2 times, and the extraction time is 0.5-1h.

[0020] Furthermore, the ethanol in step (2) is 55-70% ethanol by volume, the extraction is heating reflux extraction, and the extraction time is 1-2h.

[0021] Furthermore, after the mixing, pharmaceutically acceptable excipients are added to prepare an oral preparation.

[0022] Another object of the present invention is to provide the use of the above composition in the preparation of medicines for preventing and treating wind-heat cold or influenza, mumps, and encephalitis caused by viruses.

[0023] Beneficial effects of the present invention:

[0024] (1) The composition provided by the present invention has a good effect in preventing and treating wind-heat colds, clarifies most of the effective ingredients, and makes up for the defects of complex components and unclear efficacy of traditional Chinese medicine, which is of great significance for improving the quality of medicines and ensuring the safety of medication.

[0025] (2) In the preparation process of the present invention, Angelica dahurica and Scutellaria baicalensis are pretreated before extraction, and then extracted together with water, and the medicinal materials are extracted together with ethanol, which is beneficial to the extraction of effective ingredients and improves the antipyretic and analgesic effects.

[0026] (3) Through screening, the present invention unexpectedly discovered that imperatorin and capillary thiocarpone have a good synergistic effect in the antipyretic and analgesic effects of the present prescription. DETAILED DESCRIPTION

[0027] The technical solution of the present invention is further described below in conjunction with embodiments.

[0028] Example 1

[0029] The pharmaceutical composition of this embodiment is composed of the following components in parts by weight, as shown in Table 1.

[0030] Table 1

[0031]

[0032]

[0033] The preparation method is:

[0034] (1) Mixing Angelica dahurica and Scutellaria baicalensis, adding 1 times the amount of an aqueous solution containing 0.03% lecithin and 0.01% triglycerol monostearate at a mass concentration, soaking for pretreatment for 30 minutes, then filtering, adding 8 times the amount of water to the medicinal materials and extracting them twice at 65° C., each extraction for 0.5 hours, combining the extracts, and obtaining a medicinal residue 1 and an extract 1;

[0035] (2) Add 3 times the volume of 60% ethanol to the residue 1, heat under reflux and extract for 1 h, filter, and obtain extract 2;

[0036] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain a mixed extract;

[0037] (4) The mixed extract, forsythiaside A, puerarin, luteolin, imperatorin, capillary ketone, ABA, ABBA and oleanolic acid are mixed evenly to obtain the product.

[0038] Example 2

[0039] The pharmaceutical composition of this embodiment is composed of the following components in parts by weight, as shown in Table 2.

[0040] Table 2

[0041] Components Weight Angelica dahurica 35 Scutellaria baicalensis 50 Forsythiaside A 1 Puerarin 1 Luteolin 3 Imperatorin 2 Capillarin 5 ABA 4 ABBA 1 Oleanolic acid 0.5

[0042] The preparation method is:

[0043] (1) Mixing Angelica dahurica and Scutellaria baicalensis, adding 1 times the amount of an aqueous solution containing 0.05% lecithin and 0.02% triglycerol monostearate at a mass concentration, soaking for pretreatment for 40 minutes, then filtering, adding 8 times the amount of water to the medicinal materials and extracting them twice at 70° C., each extraction for 0.5 hours, combining the extracts, and obtaining a medicinal residue 1 and an extract 1;

[0044] (2) Add 3 times the volume of 70% ethanol to the residue 1, heat under reflux and extract for 2 h, filter, and obtain extract 2;

[0045] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain a mixed extract;

[0046] (4) The mixed extract, forsythiaside A, puerarin, luteolin, imperatorin, capillary ketone, ABA, ABBA and oleanolic acid are mixed evenly to obtain the product.

[0047] Example 3

[0048] The pharmaceutical composition of this embodiment is composed of the following components in parts by weight, as shown in Table 3.

[0049] Table 3

[0050] Components Weight Angelica dahurica 25 Scutellaria baicalensis 40 Forsythiaside A 1 Puerarin 0.5 Luteolin 1 Imperatorin 0.5 Capillarin 1 ABA 1 ABBA 0.1 Oleanolic acid 2

[0051] The preparation method is:

[0052] (1) Mixing Angelica dahurica and Scutellaria baicalensis, adding 1 times the amount of an aqueous solution containing 0.02% lecithin and 0.01% triglycerol monostearate at a mass concentration, soaking for pretreatment for 20 minutes, then filtering, adding 8 times the amount of water to the medicinal materials and extracting at 60° C. for 1 hour, to obtain a medicinal residue 1 and an extract 1;

[0053] (2) Add 3 times the volume of 55% ethanol to the residue 1, heat under reflux and extract for 1 h, filter, and obtain extract 2;

[0054] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain a mixed extract;

[0055] (4) The mixed extract, forsythiaside A, puerarin, luteolin, imperatorin, capillary ketone, ABA, ABBA and oleanolic acid are mixed evenly to obtain the product.

[0056] Comparative Example 1

[0057] The recipe is as follows:

[0058] Table 4

[0059] Components Weight Angelica dahurica 30 Scutellaria baicalensis 48 Forsythiaside A 1 Puerarin 0.6 Luteolin 2 Imperatorin 3 Capillarin / ABA 2 ABBA 1 Oleanolic acid 0.2

[0060] The preparation method is:

[0061] (1) Mixing Angelica dahurica and Scutellaria baicalensis, adding 1 times the amount of an aqueous solution containing 0.03% lecithin and 0.01% triglycerol monostearate at a mass concentration, soaking for pretreatment for 30 minutes, then filtering, adding 8 times the amount of water to the medicinal materials and extracting them twice at 65° C., each extraction for 0.5 hours, combining the extracts, and obtaining a medicinal residue 1 and an extract 1;

[0062] (2) Add 3 times the volume of 60% ethanol to the residue 1, heat under reflux and extract for 1 h, filter, and obtain extract 2;

[0063] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain a mixed extract;

[0064] (4) The mixed extract, forsythiaside A, puerarin, luteolin, imperatorin, ABA, ABBA and oleanolic acid are mixed evenly to obtain the product.

[0065] Comparative Example 2

[0066] The recipe is as follows:

[0067] Table 5

[0068]

[0069]

[0070] The preparation method is:

[0071] (1) Mixing Angelica dahurica and Scutellaria baicalensis, adding 1 times the amount of an aqueous solution containing 0.03% lecithin and 0.01% triglycerol monostearate at a mass concentration, soaking for pretreatment for 30 minutes, then filtering, adding 8 times the amount of water to the medicinal materials and extracting them twice at 65° C., each extraction for 0.5 hours, combining the extracts, and obtaining a medicinal residue 1 and an extract 1;

[0072] (2) Add 3 times the volume of 60% ethanol to the residue 1, heat under reflux and extract for 1 h, filter, and obtain extract 2;

[0073] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain a mixed extract;

[0074] (4) The mixed extract, forsythiaside A, puerarin, luteolin, capillary ketone, ABA, ABBA and oleanolic acid are mixed evenly to obtain the product.

[0075] Comparative Example 3

[0076] The recipe is as follows:

[0077] Table 6

[0078]

[0079]

[0080] The preparation method is:

[0081] (1) Mixing Angelica dahurica and Scutellaria baicalensis, adding 1 times the amount of an aqueous solution containing 0.03% lecithin and 0.01% triglycerol monostearate at a mass concentration, soaking for pretreatment for 30 minutes, then filtering, adding 8 times the amount of water to the medicinal materials and extracting them twice at 65° C., each extraction for 0.5 hours, combining the extracts, and obtaining a medicinal residue 1 and an extract 1;

[0082] (2) Add 3 times the volume of 60% ethanol to the residue 1, heat under reflux and extract for 1 h, filter, and obtain extract 2;

[0083] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain a mixed extract;

[0084] (4) The mixed extract, forsythiaside, puerarin, luteolin, imperatorin, capillarin, capillarin ketone, ABA, ABBA and oleanolic acid are mixed evenly to obtain the product.

[0085] Comparative Example 4

[0086] The pharmaceutical composition of this comparative example is composed of the following components in parts by weight, as shown in Table 7.

[0087] Table 7

[0088] Components Weight Angelica dahurica 30 Scutellaria baicalensis 48 Forsythiaside A 1 Puerarin 0.6 Luteolin 2 Imperatorin 1 Capillarin 2 ABA 2 ABBA 1 Oleanolic acid 0.2

[0089] The preparation method is:

[0090] (1) Angelica dahurica and Scutellaria baicalensis are mixed, and pre-treated by soaking in an aqueous solution containing 0.04% lecithin at a mass concentration for 30 minutes, and then filtered. The medicinal materials are heated and refluxed with 8 times the amount of water for extraction twice, each extraction is 0.5 hours, and the extracts are combined to obtain a residue 1 and an extract 1;

[0091] (2) Add 3 times the volume of 60% ethanol to the residue 1, heat under reflux and extract for 1 h, filter, and obtain extract 2;

[0092] (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain a mixed extract;

[0093] (4) The mixed extract, forsythiaside A, puerarin, luteolin, imperatorin, capillary ketone, ABA, ABBA and oleanolic acid are mixed evenly to obtain the product.

[0094] Drug efficacy test Antipyretic test

[0095] Experimental animals: SD rats, half male and half female, 6-8 weeks old, purchased from Guangdong Weitong Lihua Experimental Animal Technology Co., Ltd. During the experiment, the animals took normal feed and water. Before the experiment, they were fasted for 24 hours.

[0096] The mice were randomly divided into 8 groups, each with 10 mice, half male and half female, including acetaminophen group and experimental group.

[0097] There are 7 experimental groups in total: Example 1 to Example 3 (3 groups) and Comparative Example 1 to Comparative Example 4 (4 groups).

[0098] Before modeling, the rectal temperature was measured three times, each time at an interval of 1 hour, and the average value was recorded as the basal body temperature; then each group of rats was intraperitoneally injected with 2,4-dinitrophenol 15 mg / kg to induce fever. Then, the corresponding group of drugs were given to each group of rats by gavage, and the specific administration and dosage are shown in Table 1. The rectal temperature was measured again 1 hour, 2 hours, and 3 hours after the last administration. The temperature difference before and after fever was calculated, and the results are shown in Table 1.

[0099] Table 1 Fever of rats in different groups

[0100]

[0101] Note: Compared with Example 1, △ P<0.05.

[0102] The data in Table 1 show that the pharmaceutical composition provided by the present invention has a better effect of lowering the body temperature of rats, indicating that the drug of the present invention has a stable efficacy and a good antipyretic effect.

[0103] Drug efficacy test Analgesia test

[0104] Experimental animals: Kunming mice, 18-22g. Randomly divided into 9 groups, 10 mice in each group, half male and half female. They are model group, positive acetaminophen group; experimental groups total 7 groups: Example 1 to Example 3 (3 groups) and Comparative Example 1 to Comparative Example 4 (4 groups).

[0105] Dosage method: At the beginning of the experiment, except for the model group, each group of mice was gavaged once, and the dosage was as shown in Table 2. One hour after gavage, 0.2 mg of 0.3% acetic acid was injected intraperitoneally, and the number of twisting times of mice in each group within 30 minutes was recorded. The results are shown in Table 2.

[0106] Table 2

[0107]

[0108] Note: Compared with the model group # P<0.05, ## P<0.01; compared with the Example 1 group, △ P<0.05.

[0109] The data in Table 2 show that the analgesic effect of the pharmaceutical composition provided by the present invention indicates that the drug of the present invention exerts a stable efficacy and has a good antipyretic effect.

[0110] The above detailed description is a specific description of one feasible embodiment of the present invention. The embodiment is not intended to limit the patent scope of the present invention. Any equivalent implementation or modification that does not deviate from the present invention should be included in the scope of the technical solution of the present invention.

Claims

1. A pharmaceutical composition of Kanggan Jiedu capsules, characterized in that: The composition consists of the following components in parts by weight: 25-35 parts of angelica dahurica, 40-50 parts of scutellaria baicalensis, 2-5 parts of flavonoid compounds, 0.5-2 parts of imperatorin, 1-5 parts of capillary ketone, 1-5 parts of phloroglucinol compounds and 0.1-0.5 parts of organic acid.

2. The composition according to claim 1, characterized in that The phloroglucinol compounds include ABA and ABBA in a mass ratio of 1-5:

1.

3. The composition according to claim 1, characterized in that The organic acid is selected from one or more of oleanolic acid, vanillic acid and lauric acid.

4. The composition according to claim 1, characterized in that The organic acid is oleanolic acid.

5. The composition according to claim 1, characterized in that In terms of weight, the flavonoid compound comprises a mixture of forsythiaside A, puerarin and luteolin in a mass ratio of 1:0.5-1:1-3.

6. A method for preparing the composition according to any one of claims 1 to 5, characterized in that: The steps include: (1) mixing Angelica dahurica and Scutellaria baicalensis, adding additives for soaking pretreatment, filtering, adding water for extraction, and obtaining a residue 1 and an extract 1; (2) extracting the residue 1 with ethanol, filtering, and obtaining an extract 2; (3) mixing the extract 1 and the extract 2, concentrating and drying to obtain an extract; (4) The extract, flavonoid compounds, imperatorin, capillary ketone, phloroglucinol compounds and organic acid are mixed to obtain the product.

7. The preparation method according to claim 6, characterized in that: The additive in step (1) is an aqueous solution containing 0.02-0.05% lecithin and 0.01-0.02% polyglycerol fatty acid ester by mass concentration; the pretreatment time is 20-40 minutes, the extraction temperature is 60-70° C., the number of extractions is 1-2 times, and the extraction time is 0.5-1 hour.

8. The preparation method according to claim 6, characterized in that: The ethanol in step (2) is 55-70% ethanol by volume, the extraction is heating reflux extraction, and the extraction time is 1-2h.

9. The preparation method according to claim 8, characterized in that: After the mixing, pharmaceutically acceptable adjuvants are added to prepare oral preparations.

10. Use of the composition according to any one of claims 1 to 5 in the preparation of a medicament for preventing and treating wind-heat cold, influenza caused by viruses, mumps or encephalitis.

Citation Information

Patent Citations

  • Preparation method of sugar-free anti-influenza detoxification granule

    CN103330770A

  • Preparation method for anti-flu detoxification granules

    CN108853028A